Free Trial

Canopy Growth (CGC) to Release Earnings on Friday

Canopy Growth logo with Medical background

Canopy Growth (NASDAQ:CGC - Get Free Report) will likely be releasing its Q3 2025 earnings data before the market opens on Friday, February 7th. Analysts expect Canopy Growth to post earnings of ($0.38) per share and revenue of $69.45 million for the quarter. Individual that are interested in participating in the company's earnings conference call can do so using this link.

Canopy Growth Stock Down 27.3 %

NASDAQ CGC traded down $0.76 during trading hours on Friday, reaching $2.02. 22,890,203 shares of the company's stock traded hands, compared to its average volume of 7,716,115. Canopy Growth has a 52-week low of $1.85 and a 52-week high of $14.92. The firm has a market cap of $263.47 million, a PE ratio of -0.41 and a beta of 0.86. The firm has a 50-day simple moving average of $2.70 and a 200 day simple moving average of $4.26. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.39 and a quick ratio of 1.07.

Wall Street Analyst Weigh In

Separately, Atb Cap Markets lowered shares of Canopy Growth from a "hold" rating to a "strong sell" rating in a research note on Monday, December 16th.

View Our Latest Research Report on CGC

About Canopy Growth

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.

Recommended Stories

Earnings History for Canopy Growth (NASDAQ:CGC)

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines